Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Common Stock, par value $0.001 per share · CUSIP: 56854Q200

Event date: 2025-02-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLC

    Shares: 3,022,612.00 · Class: 5.5%

  • Averill Master Fund, Ltd.

    Shares: 3,022,612.00 · Class: 5.5%

  • Aaron Cowen

    Shares: 3,022,612.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-000967
Form type
SCHEDULE 13G
Filer
MARINUS PHARMACEUTICALS, INC.
CIK
CIK 1267813
Filed
Feb 11, 2025
Reporting period
Feb 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub